col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


16 Ergebisse       Seite 1

 [1] 
JPPS Journal: Journal of Pharmacy & Pharmaceutical Sciences
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2023―Jun―30 COVID-19 mRNA vaccination is associated with IgA nephropathy: an analysis of the Japanese adverse drug event report database Hiroka Nakao, Takenao Koseki, Koki Kato, Shigeki Yamada, Naotake Tsuboi, Kazuo Takahashi, Tomohiro Mizuno
2 [GO] 2022―Sep―12 Efficacy and Safety of Anticoagulants for COVID-19 Patients in the Intensive Care Unit: A Systematic Review and Meta-Analysis Vina Neldi, Budi Suprapti, Alfian Nur Rosyid
3 [GO] 2022―Jun―02 The Effect of HIV/AIDS Infection on the Clinical Outcomes of COVID-19: A Meta-Analysis Yousef Moradi, Marzieh Soheili, Hojat Dehghanbanadaki, Ghobad Moradi, Farhad Moradpour, Seyede Maryam Mahdavi Mortazavi, et al. (+2)
4 [GO] 2022―Apr―02 Association Between Vitamin D Levels and Inflammatory Markers in COVID-19 Patients: A Meta-Analysis of Observational Studies Robert Hopefl, Mohamed Ben-Eltriki, Subrata Deb
5 [GO] 2022―Mrz―02 Effects of Vitamin D Serum Level on Morbidity and Mortality in Patients with COVID-19: A Systematic Review and Meta-Analysis Yiyun Hu, Janice Kung, Andrew Cave, Hoan Linh Banh
6 [GO] 2021―Jul―28 Losartan Inhibits SARS-CoV-2 Replication in Vitro Reza Nejat, Ahmad Shahir Sadr, Branden Freitas, Jackelyn Crabttree, Scott D. Pegan, Ralph A. Tripp, David Najafi
7 [GO] 2021―Jul―15 Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India Ranjini Roy, Chandrima Pattadar, Rishav Raj, Neeraj Agarwal, Bijit Biswas, Pramod Kumar Manjhi, et al. (+3)
8 [GO] 2021―Mai―22 Lopinavir/Ritonavir for COVID-19: a Systematic Review and Meta-Analysis Bahman Amani, Ahmad Khanijahani, Behnam Amani, Payam Hashemi
9 [GO] 2021―Mai―17 Safety and Efficacy of Remdesivir for the Treatment of COVID-19: A Systematic Review and Meta-Analysis Mohammad Tasavon Gholamhoseini, Vahid Yazdi-Feyzabadi, Reza Goudarzi, Mohammad Hossein Mehrolhassani
10 [GO] 2021―Mai―15 Role of OATP4C1 in Renal Handling of Remdesivir and its Nucleoside Analog GS-441524: The First Approved Drug for Patients with COVID-19 Toshihiro Sato, Masamitsu Maekawa, Nariyasu Mano, Takaaki Abe, Hiroaki Yamaguchi
11 [GO] 2021―Mai―03 Clinical Outcomes of COVID-19 Patients Treated with Convalescent Plasma or Remdesivir Alone and in Combination at a Community Hospital in California’s Central Valley Regine Padilla, Jered Arquiette, Yvonne Mai, Gurinder Singh, Kristine Galang, Edward Liang
12 [GO] 2021―Feb―22 Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes Ceren Guney, Fatma AKAR
13 [GO] 2020―Okt―19 Assessing the Elevation of Cardiac Biomarkers and the Severity of COVID-19 Infection: A Meta-analysis Cucnhat Walker, Subrata Deb, Hua Ling, Zhe Wang
14 [GO] 2020―Jul―31 Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-2 Hamed Gilzad-Kohan, Fakhreddin Jamali
15 [GO] 2020―Apr―23 Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients Zsuzsanna Suba
16 [GO] 2020―Apr―05 Current Drugs with Potential for Treatment of COVID-19: A Literature Review Md Insiat Islam Rabby
 [1] 

16 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.013 sec